The story of Viagra, and its parent company copyright, presents a challenging case study for investors. Originally a blockbuster drug, generating billions in revenue , its exclusivity period created a flood of generic competition , significantly diminishing its market share . While certain pharmaceutical companies may try to capitalize on related t